Form D · Biotechnology
Petragen, Inc.
Davie, FL · CIK 0001844157
Offering snapshot reported Jun 23, 2026 · SEC filing
- Reported sold
- $495K Offering amount: $1M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 5, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2026 | Initial | $495,000 | No comparison | 9 | SEC filing |
| Feb 16, 2022 | Amendment | $1,882,307 | $1,231,581vs Feb 4, 2021 | 39 | SEC filing |
| Feb 4, 2021 | Initial | $650,726 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $100K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-588229
Common Shares
Estimated 10% commission on total sales plus warrants (amount based on target amount as of date of Form D).
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Bradley Woods & Co. Ltd. | 000013660 | none |
Source: Form D, filed Jun 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Demetrios Braddock, Md, Ph D | Executive |
| David Kolb | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12555 Orange Drive, Suite 236
Davie, FL, 33330
Davie, FL, 33330